Possible Treatment of Mycobacterium Lepramatous with Bovine Milk
Jesus’ Christus,
Michael Arden Madson
Issue:
Volume 2, Issue 3, September 2018
Pages:
55-61
Received:
26 August 2018
Accepted:
12 September 2018
Published:
17 December 2018
Abstract: Biochemical etiology of M. lepromatous suggests binding to a sialyl group on the endothelial cell surface. This binding is known to occur for binding of ICAM 1, VCAM 1 and VLA 4 to TLR-2. Post translational modification on TLR 2, on the cell surface and which initiates cell’s immune response, is, here, postulated to contain a sialyl group for binding to M. lepromatous. We hope bBinding of M. lepromatous to sialyl (α2->3) galactosyl (β 1->4) linked TLR-2, on human gut endothelial cells is may be prevented with ingestion of bovine milk because of the presence of sialylated lactose 6’ phospho di-phospho asparaginyl sulfo tyrosine dipeptide in bovine milk. To establish the structure of this bovine milk component through the use of mass spectrometry and high performance anion exchange chromatography with pulsed amperometric detection (HPAEC-PAD) is sought. And thereby propose the use of bovine milk to treat M. lepromatous. Since no viable way to test bovine milk components for binding to M. lepromatous due to the difficulty of culturing the microbe testing in humans is suggested to be done. Here, to we characterize the structure of milk oligosaccharide, which is essential to moving forward with treatment of M. lepromatous infection with bovine milk.
Abstract: Biochemical etiology of M. lepromatous suggests binding to a sialyl group on the endothelial cell surface. This binding is known to occur for binding of ICAM 1, VCAM 1 and VLA 4 to TLR-2. Post translational modification on TLR 2, on the cell surface and which initiates cell’s immune response, is, here, postulated to contain a sialyl group for bindi...
Show More
